Artal International S.C.A. Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

LXRX Quotes by TradingView

Artal International S.C.A. Transaction History

Date Transaction Value Shares Traded Form
May 10 2024
BUY
Exercise of conversion of derivative security
-
57,546,100
Mar 13 2024
BUY
Grant, award, or other acquisition
$124,875,037 $108.5 p/Share
1,150,922
Jun 05 2023
BUY
Open market or private purchase
$72,215,130 $2.6 p/Share
27,775,050
Aug 05 2022
BUY
Open market or private purchase
$6,065,175 $2.5 p/Share
2,426,070
Aug 01 2022
BUY
Open market or private purchase
$40,434,500 $2.5 p/Share
16,173,800
Dec 16 2020
BUY
Open market or private purchase
$35,000,001 $3.2 p/Share
10,937,500

Also insider at

SRRK
Scholar Rock Holding Corp Healthcare
> 10% Shareholder
CAVA
CAVA GROUP, INC.
AIS

Artal International S.C.A.

Luxembourg, N4

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXRX